Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.3 USD | -3.23% | -10.83% | +23.54% |
May. 09 | Adverum Biotechnologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | HC Wainwright Starts Adverum Biotechnologies With Buy Rating, $30 Price Target | MT |
Financials (USD)
Sales 2024 * | 314K | Sales 2025 * | 8.87M | Capitalization | 193M |
---|---|---|---|---|---|
Net income 2024 * | -115M | Net income 2025 * | -140M | EV / Sales 2024 * | 141 x |
Net cash position 2024 * | 149M | Net cash position 2025 * | 136M | EV / Sales 2025 * | 6.48 x |
P/E ratio 2024 * |
-1.69
x | P/E ratio 2025 * |
-1.73
x | Employees | 121 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.65% |
Latest transcript on Adverum Biotechnologies, Inc.
1 day | -3.23% | ||
1 week | -10.83% | ||
Current month | -4.32% | ||
1 month | -22.37% | ||
3 months | -46.24% | ||
6 months | -0.69% | ||
Current year | +23.54% |
Managers | Title | Age | Since |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 22-12-11 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Whitcup
BRD | Director/Board Member | 64 | 20-04-15 |
Clarence Machado
CHM | Chairman | 60 | 17-03-13 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 9.3 | -3.23% | 340,268 |
24-05-09 | 9.61 | -2.04% | 212,194 |
24-05-08 | 9.81 | -5.13% | 200,543 |
24-05-07 | 10.34 | -3.00% | 340,343 |
24-05-06 | 10.66 | +2.21% | 206,614 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.54% | 193M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- ADVM Stock